Related references
Note: Only part of the references are listed.First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial
Maria M. E. Jongsma et al.
GUT (2022)
The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update
Patrick F. van Rheenen et al.
JOURNAL OF CROHNS & COLITIS (2021)
Role of Thiopurines in Pediatric Inflammatory Bowel Diseases: A Real-Life Prospective Cohort Study
Ohad Atia et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2020)
Diagnostic and Therapeutic Approach in Paediatric Inflammatory Bowel Diseases: Results from a Clinical Practice Survey
Jiri Bronsky et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2019)
Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment
Joany E. Kreijne et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial
Arie Levine et al.
GASTROENTEROLOGY (2019)
Treatment of Active Crohn's Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition
Vaios Svolos et al.
GASTROENTEROLOGY (2019)
Machine Learning Algorithms for Objective Remission and Clinical Outcomes with Thiopurines
Akbar K. Waljee et al.
JOURNAL OF CROHNS & COLITIS (2017)
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study
Subra Kugathasan et al.
LANCET (2017)
A validated web-based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variables
C. A. Siegel et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis
Stefanos Bonovas et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Time to Relapse in Children with Crohn's Disease Treated with Azathioprine and Nutritional Therapy or Corticosteroids
Ondrej Hradsky et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease
Christian Mottet et al.
INFLAMMATORY BOWEL DISEASES (2016)
Serum C-reactive Protein and CRP Genotype in Pediatric Inflammatory Bowel Disease: Influence on Phenotype, Natural History, and Response to Therapy
Paul Henderson et al.
INFLAMMATORY BOWEL DISEASES (2015)
Comparison of Outcomes Parameters for Induction of Remission in New Onset Pediatric Crohn's Disease: Evaluation of the Porto IBD Group Growth Relapse and Outcomes with Therapy (GROWTH CD) Study
Arie Levine et al.
INFLAMMATORY BOWEL DISEASES (2014)
Hepatosplenic T-cell lymphoma, immunosuppressive agents and biologicals: what are the risks?
K. Subramaniam et al.
INTERNAL MEDICINE JOURNAL (2014)
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
F. M. Ruemmele et al.
JOURNAL OF CROHNS & COLITIS (2014)
ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents
Arie Levine et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2014)
Disease Phenotype at Diagnosis in Pediatric Crohn's Disease: 5-year Analyses of the EUROKIDS Registry
Charlotte I. de Bie et al.
INFLAMMATORY BOWEL DISEASES (2013)
Exploring Associations of 6-Thioguanine Nucleotide Levels and Other Predictive Factors with Therapeutic Response to Azathioprine in Pediatric Patients with IBD Using Multilevel Analysis
Thi-Van-Anh Nguyen et al.
INFLAMMATORY BOWEL DISEASES (2013)
Antitumor necrosis factor treatment for pediatric inflammatory bowel disease
Charlotte I. de Bie et al.
INFLAMMATORY BOWEL DISEASES (2012)
Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn's disease in children: REACH open-label extension
Jeffrey Hyams et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Real-time Tool to Display the Predicted Disease Course and Treatment Response for Children with Crohn's Disease
Corey A. Siegel et al.
INFLAMMATORY BOWEL DISEASES (2011)
Tolerance and Efficacy of Azathioprine in Pediatric Crohn's Disease
Laura Riello et al.
INFLAMMATORY BOWEL DISEASES (2011)
Development of the Crohn's Disease Digestive Damage Score, the Lemann Score
Benjamin Pariente et al.
INFLAMMATORY BOWEL DISEASES (2011)
The Impact of Thiopurines on the Risk of Surgical Recurrence in Patients With Crohn's Disease After First Intestinal Surgery
Pavol Papay et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Thiopurine S-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment; a pharmacogenomic test whose time has come
L. T. Ford et al.
JOURNAL OF CLINICAL PATHOLOGY (2010)
Risk of Lymphoma Associated With Combination Anti-Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis
Corey A. Siegel et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Efficacy of Infliximab in Pediatric Crohn's Disease: A Randomized Multicenter Open-label Trial Comparing Scheduled to On Demand Maintenance Therapy
Frank M. Ruemmele et al.
INFLAMMATORY BOWEL DISEASES (2009)
Step-Up and Top-Down Approaches to the Treatment of Crohn's Disease: Early May Already Be Too Late
Laurent Peyrin-Biroulet et al.
GASTROENTEROLOGY (2008)
Effect of early immunomodulator use in moderate to severe pediatric Crohn disease
Jaya Punati et al.
INFLAMMATORY BOWEL DISEASES (2008)
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease:: an open randomised trial
Geert D'Haens et al.
LANCET (2008)
Azathioprine maintains first remission in newly diagnosed pediatric Crohn's disease
Gerald J. Jaspers et al.
INFLAMMATORY BOWEL DISEASES (2006)
Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease
U. Hindorf et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Risk factors for initial surgery in pediatric patients with Crohn's disease
N Gupta et al.
GASTROENTEROLOGY (2006)
Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease
RB Gearry et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2004)
Increased incidence of azathioprine-induced pancreatitis in Crohn's disease compared with other diseases
RK Weersma et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
High-dose azathioprine in children with inflammatory bowel disease
D Fuentes et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine
GA Dayharsh et al.
GASTROENTEROLOGY (2002)
A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease
J Markowitz et al.
GASTROENTEROLOGY (2000)
Share Paper
